E.K. Manesis

584 total citations
21 papers, 413 citations indexed

About

E.K. Manesis is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, E.K. Manesis has authored 21 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 11 papers in Hepatology and 2 papers in Infectious Diseases. Recurrent topics in E.K. Manesis's work include Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (8 papers). E.K. Manesis is often cited by papers focused on Hepatitis C virus research (10 papers), Liver Disease Diagnosis and Treatment (9 papers) and Hepatitis B Virus Studies (8 papers). E.K. Manesis collaborates with scholars based in Greece, United States and Switzerland. E.K. Manesis's co-authors include Melanie Deutsch, S. Hadziyannis, C.H. Cameron, Spyridon P. Dourakis, G Hess, Andrea Horsch, Gregory Gregoriadis, Athanasios J. Archimandritis, Maria Tzetis and Emmanuel Kanavakis and has published in prestigious journals such as Hepatology, FEBS Letters and Journal of Hepatology.

In The Last Decade

E.K. Manesis

20 papers receiving 381 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E.K. Manesis Greece 9 205 203 70 52 47 21 413
Motoko Fujii Japan 9 131 0.6× 163 0.8× 61 0.9× 24 0.5× 44 0.9× 14 351
Kouichi Takaguchi Japan 13 489 2.4× 498 2.5× 30 0.4× 9 0.2× 25 0.5× 31 600
Keiji Kita Japan 8 228 1.1× 233 1.1× 31 0.4× 8 0.2× 37 0.8× 23 358
P. Guarascio Italy 11 115 0.6× 152 0.7× 22 0.3× 17 0.3× 43 0.9× 21 304
Guozhong Gong China 8 381 1.9× 405 2.0× 24 0.3× 10 0.2× 170 3.6× 18 670
Guy Vautier United Kingdom 10 113 0.6× 27 0.1× 107 1.5× 11 0.2× 64 1.4× 16 438
Shin Fujioka Japan 11 206 1.0× 140 0.7× 11 0.2× 4 0.1× 153 3.3× 36 479
Gregory W. Svanas United States 9 62 0.3× 129 0.6× 12 0.2× 8 0.2× 92 2.0× 14 337
Mohamed A. Metwally Egypt 8 168 0.8× 160 0.8× 30 0.4× 5 0.1× 22 0.5× 33 288

Countries citing papers authored by E.K. Manesis

Since Specialization
Citations

This map shows the geographic impact of E.K. Manesis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E.K. Manesis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E.K. Manesis more than expected).

Fields of papers citing papers by E.K. Manesis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E.K. Manesis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E.K. Manesis. The network helps show where E.K. Manesis may publish in the future.

Co-authorship network of co-authors of E.K. Manesis

This figure shows the co-authorship network connecting the top 25 collaborators of E.K. Manesis. A scholar is included among the top collaborators of E.K. Manesis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E.K. Manesis. E.K. Manesis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Athanasopoulos, Stavros, Asimina Mitrakou, Melanie Deutsch, et al.. (2024). Addition of Dulaglutide or Empagliflozin to Standard-of-Care Treatment: Effect on Liver Steatosis in Patients With Type 2 Diabetes Mellitus. Cureus. 16(2). e53813–e53813. 1 indexed citations
2.
Chrysanthos, N., et al.. (2018). Metastatic Signet-Ring Cell Carcinoma of the Skin. The American Journal of Gastroenterology. 113(10). 1427–1427. 2 indexed citations
3.
Buzzetti, Elena, Mattias Ekstedt, Tu Vinh Luong, et al.. (2017). Collagen proportion area is an independent predictor of longterm outcome in patients with non-alcoholic fatty liver disease. Journal of Hepatology. 66(1). S52–S52. 1 indexed citations
4.
Papatheodoridis, George, Spilios Manolakopoulos, Giota Touloumi, et al.. (2013). 766 HEPATOCELLULAR CARCINOMA (HCC) RISK IN HBeAg-NEGATIVE CHRONIC HEPATITIS B (CHBe−) WITH OR WITHOUT CIRRHOSIS TREATED WITH ENTECAVIR: RESULTS OF THE NATIONWIDE HepNet.Greece COHORT STUDY. Journal of Hepatology. 58. S312–S312. 6 indexed citations
5.
Manolakopoulos, Spilios, et al.. (2010). Substitution treatment or active intravenous drug use should not be contraindications for antiviral treatment in drug users with chronic hepatitis C. Liver International. 30(10). 1454–1460. 19 indexed citations
6.
Tsochatzis, Emmanuel, George Papatheodoridis, Spilios Manolakopoulos, et al.. (2009). Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B. Scandinavian Journal of Gastroenterology. 44(6). 752–759. 26 indexed citations
7.
Papatheodoridis, George, Emilia Hadziyannis, Emmanuel Tsochatzis, et al.. (2008). Serum apoptotic caspase activity as a marker of severity in chronic hepatitis C virus infection. Annals of Gastroenterology. 21(1). 39–44. 1 indexed citations
8.
Koskinas, John, Melanie Deutsch, Georgia Kostopanagiotou, et al.. (2008). Aetiology and outcome of acute hepatic failure in Greece: experience of two academic hospital centres. Liver International. 28(6). 821–827. 11 indexed citations
9.
Papatheodoridis, George, E.K. Manesis, Spilios Manolakopoulos, et al.. (2007). [481] HBeAg-NEGATIVE CHRONIC HEPATITIS B (CHBe-) IN CHRONIC HBV PATIENTS WITH SERUM HBV-DNA LEVELS BELOW 2,000 lU/mL. Journal of Hepatology. 46. S183–S183. 2 indexed citations
10.
Tsochatzis, Emmanuel, John Koskinas, E.K. Manesis, & Athanasios J. Archimandritis. (2007). Liver Transplantation in Greek Patients: Epidemiological Data, Morbidity, and Mortality of 71 Patients from a Single Center With 6 Years of Mean Follow-up. Transplantation Proceedings. 39(5). 1505–1507. 4 indexed citations
11.
Papatheodoridis, George, Emilia Hadziyannis, Emmanuel Tsochatzis, et al.. (2007). [749] SERUM APOPTOTIC CASPASE ACTIVITY AS MARKER OF DISEASE SEVERITY IN CHRONIC HEPATITIS C (CH-C) OR NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD). Journal of Hepatology. 46. S282–S282. 1 indexed citations
12.
Baou, Katerina, Charalambos Vlachopoulos, E.K. Manesis, et al.. (2007). P.027 AORTIC STIFFNESS IS INCREASED IN PATIENTS WITH HEPATITIS C VIRUS SEROPOSITIVITY. Artery Research. 1(S1). S34–S34. 1 indexed citations
13.
Koskinas, John, et al.. (2006). 725 Liver involvement in acute vaso-occlusive crisis of patients with sickle cell disease: Prevalence and predisposing factors. Journal of Hepatology. 44. S266–S267. 1 indexed citations
14.
Panagiotakaki, Eleni, Maria Tzetis, Nina Manolaki, et al.. (2004). Genotype–phenotype correlations for a wide spectrum of mutations in the Wilson disease gene (ATP7B). American Journal of Medical Genetics Part A. 131A(2). 168–173. 70 indexed citations
15.
Tsiodras, Sotirios, et al.. (2004). Deep sinus aspergillosis in a liver transplant recipient successfully treated with a combination of caspofungin and voriconazole. Transplant Infectious Disease. 6(1). 37–40. 22 indexed citations
16.
17.
Manesis, E.K., George Papatheodoridis, & Αlexandra Alexopoulou. (2003). Treatment of HBEAG-negative chronic hepatitis B (CHBE-) with sequential lamivudine (LAM) and Interferon-ALFA (IFN) courses of 12-mouth duration and a 6-month overlap. Journal of Hepatology. 38. 152–153. 1 indexed citations
18.
19.
Deutsch, Melanie, Spyridon P. Dourakis, E.K. Manesis, et al.. (1997). Thyroid abnormalities in chronic viral hepatitis and their relationship to interferon alfa therapy. Hepatology. 26(1). 206–210. 136 indexed citations
20.
Manesis, E.K., C.H. Cameron, & Gregory Gregoriadis. (1979). Hepatitis B surface antigen‐containing liposomes enhance humoral and cell‐mediated immunity to the antigen. FEBS Letters. 102(1). 107–111. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Motoko Fujii Breakdown of academic impact, for papers by Kouichi Takaguchi Breakdown of academic impact, for papers by Keiji Kita Breakdown of academic impact, for papers by P. Guarascio Breakdown of academic impact, for papers by Guozhong Gong Breakdown of academic impact, for papers by Guy Vautier Breakdown of academic impact, for papers by Shin Fujioka Breakdown of academic impact, for papers by Gregory W. Svanas Breakdown of academic impact, for papers by Mohamed A. Metwally
Rankless by CCL
2026